Physician

Juan Aponte, MD

According to 2025 Medicare claims, Juan Aponte, MD (NPI: 1376526947) practices internal medicine in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24501-2115. Aponte is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Aponte's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 649 traditional Medicare patients, billed 18,728 HCPCS/CPT codes, and received $363,305 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,232 prescription claims across 979 beneficiaries totaling $1,663,478 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,149 claims. Open Payments data shows 53 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $227,261 to $363,305. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	891	5,847	$227,261
2016	834	6,626	$214,795
2017	688	6,588	$212,008
2018	1,052	10,635	$351,011
2019	841	14,050	$390,758
2020	781	14,819	$375,390
2021	761	20,233	$367,477
2022	694	16,545	$385,632
2023	655	14,928	$359,468
2024	649	18,728	$363,305

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	618	19,376	$1,236,149
2016	572	18,850	$1,084,292
2017	554	18,559	$1,078,948
2018	885	20,380	$1,343,828
2019	883	17,840	$1,288,074
2020	815	16,801	$1,298,497
2021	835	13,330	$1,163,668
2022	871	13,478	$1,393,943
2023	832	13,304	$1,491,663
2024	979	15,232	$1,663,478

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	127	885	$45,922
2016	241	1,229	$40,211
2017	249	1,333	$27,610
2018	168	1,019	$20,586
2019	235	862	$19,194
2020	312	1,009	$68,473
2021	354	960	$85,172
2022	285	835	$33,867
2023	391	1,041	$149,875
2024	390	1,149	$158,442

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	628	1,690	$81
80061	Blood test, lipids (cholesterol and triglycerides)	586	1,038	$13
36415	Insertion of needle into vein for collection of blood sample	603	1,296	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	589	1,152	$8
80076	Liver function blood test panel	583	1,037	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	144	8,626	$279,131
Eliquis	Apixaban	143	9,122	$174,423
Mounjaro	Tirzepatide	133	4,678	$165,259
Jardiance	Empagliflozin	81	5,950	$116,825
Enbrel Sureclick	Etanercept	11	308	$80,880

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$106,338
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	28	$12,626
E0601	Continuous positive airway pressure (cpap) device	Y	31	204	$6,242
A7032	Cushion for use on nasal mask interface, replacement only, each	N	24	64	$5,880
A7031	Face mask interface, replacement for full face mask, each	N	23	52	$4,233

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$731	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Juan Aponte, MD?

Tedicare shows public-source Medicare data for Juan Aponte, MD (NPI 1376526947), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Juan Aponte, MD have ACO affiliation data?

Juan Aponte, MD is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Juan Aponte, MD?

Juan Aponte, MD is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Juan Aponte, MD have Open Payments data?

Juan Aponte, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.